Cargando…
Mir-26b inhibits growth and resistance to paclitaxel chemotherapy by silencing the CDC6 gene in gastric cancer
INTRODUCTION: Gastric cancer is one of the most common cancers of the digestive system and is associated with high morbidity and mortality. The aim of this study was to investigate whether miR-26b is involved in the proliferation and resistance to paclitaxel chemotherapy in gastric cancer cells. MAT...
Autores principales: | Zhao, Bochao, Zhang, Jiale, Chen, Xiuxiu, Xu, Huimian, Huang, Baojun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425209/ https://www.ncbi.nlm.nih.gov/pubmed/30899303 http://dx.doi.org/10.5114/aoms.2018.73315 |
Ejemplares similares
-
Silence of cancer susceptibility candidate 9 inhibits gastric cancer and reverses chemoresistance
por: Shang, Chao, et al.
Publicado: (2017) -
Correction: Silence of cancer susceptibility candidate 9 inhibits gastric cancer and reverses chemoresistance
por: Shang, Chao, et al.
Publicado: (2022) -
Central lymph node metastasis is predictive of survival in advanced gastric cancer patients treated with D2 lymphadenectomy
por: Lu, Huiwen, et al.
Publicado: (2021) -
Paclitaxel inhibits growth, migration and collagen production of human Tenon's fibroblasts—potential use in drug-eluting glaucoma drainage devices
por: Choritz, Lars, et al.
Publicado: (2009) -
5,7,2,5-tetrahydroxy-8,6-dimethoxyflavone up-regulates miR-145 expression and inhibits proliferation of gastric cancer cells
por: Wei, Chunhong, et al.
Publicado: (2021)